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Chromosome segregation errors can
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whereas structural imbalances that result
from segregation errors cannot.
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The presence of an abnormal karyotype has been
shown to be profoundly detrimental at the cellular
and organismal levels but is an overt hallmark of
cancer. Aneuploidy can lead to p53 activation and
thereby prevents proliferation, but the exact trigger
for p53 activation has remained controversial. Here,
we have used a system to induce aneuploidy in un-
transformed human cells to explore how cells deal
with different segregation errors. We show that p53
is activated only in a subset of the cells with altered
chromosome content. Importantly, we find that at
least a subset of whole-chromosome aneuploidies
can be propagated in p53-proficient cells, indicating
that aneuploidy does not always lead to activation of
p53. Finally, we demonstrate that propagation of
structural aneuploidies (gain or loss of part of a chro-
mosome) induced by segregation errors is limited to
p53-deficient cells.
INTRODUCTION
Segregation of chromosomes is known to fail occasionally in
normal cells and more frequently in cancer cells, resulting in
offspring that inherit a different complement of chromosomes,
a state that is referred to as aneuploidy (Holland and Cleveland,
2009). Aneuploidy has been shown to be profoundly detrimental
at both the cellular and organismal levels in all species tested to
date (Gordon et al., 2012). One profound consequence of aneu-
ploidy, originally observed in fibroblasts of Down syndrome pa-
tients, is their impaired proliferative capacity (Segal and McCoy,
1974). This phenotype is now well described for different spe-
cies, such as yeast (Torres et al., 2007) and mice (Williams
et al., 2008). The proliferative disadvantage might be explained
in several ways, as aneuploid cells exhibit a variety of stress-
related phenotypes (Tang et al., 2011; Torres et al., 2007).
Aneuploidy can lead to activation of p53 (Santaguida and
Amon, 2015), but how p53 activation is triggered in response to
aneuploidy has remained a controversial matter. It has been pro-Cell
This is an open access article under the CC BY-Nposed that aneuploidy per se can activate p53 either through the
p38 stress kinase (Thompson and Compton, 2010) or because of
elevated levels of DNAdamage induced by increased production
of reactive oxygen species (Li et al., 2010). Alternatively, chromo-
some segregation errors were shown to produce DNA breaks
that activate p53 through the activation of ATM (Janssen et al.,
2011). Finally, an increased mitotic duration, which is often asso-
ciated with erroneous chromosome segregation, can induce p53
via a p38-dependent pathway (Uetake and Sluder, 2010). To un-
derstand how abnormal karyotypes can arise and be propa-
gated, we need a better appreciation of the direct consequences
of de novo aneuploidy on p53 activation.
Here, we have induced de novo aneuploidies in non-trans-
formed retinal pigment epithelial (RPE-1) cells in both p53-profi-
cient and p53-deficient backgrounds. Interestingly, we find that
p53 is not always activated in response to induced aneuploidy,
arguing that p53 is not inevitably activated by aneuploidy per
se. Importantly, we find that structural aneuploidies produced
from segregation errors trigger p53 activation, and hence their
propagation is limited to p53-deficient cells. In contrast, we
show that not all whole-chromosome aneuploidies trigger p53
activation and that at least a subset of these is tolerated in
p53-proficient backgrounds.RESULTS
Induction of Chromosome Aneuploidies
To study the effects of induced aneuploidy, we selected a stable,
near-diploid, non-transformed human cell line, RPE-1, and
included an RPE-1-derived cell line with a stable short hairpin
RNA (shRNA)-mediated knockdown of p53 (Figures S1A and
S1B). Previous systems to induce aneuploidy mostly involved
treatments with drugs that block cells in mitosis, followed by
drug washout to allow mitotic progression with increased
numbers of faulty attached chromosomes (Crasta et al., 2012;
Janssen et al., 2011; Thompson and Compton, 2010). However,
it was previously shown that prolonged mitotic timing results in a
p53-dependent G1 arrest (Uetake and Sluder, 2010). To prevent
a mitotic delay, we interfered with the mitotic checkpoint as a
way to induce aneuploidy. Treatment with an MPS1 inhibitor at
a dose that fully inactivates the mitotic checkpoint (Koch et al.,Reports 19, 2423–2431, June 20, 2017 ª 2017 The Author(s). 2423
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A0h 22h 44h36h 40h
B
C
E
F
D
plate cells
RPE-1 wt or p53kd
+thymidine
single cell
plating
microscopically
select MN
cells
harvest cells
and prepare 
for SCS
Lo
g2
 ra
tio
2
-2
0
CNV analysis - RPE-1 wt
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1819202122 X
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1819202122 X
CNV analysis - RPE-1 p53kd
G
release from thymidine
+addition of 
Mps1i +/- CENP-Ei
3-somy
4-somy
state
0-somy
1-somy
2-somy
3-somy
4-somy
state
0-somy
1-somy
2-somy
P
ar
en
ta
l w
t (
22
 c
el
ls
)
P
ar
en
ta
l p
53
kd
(1
5 
ce
lls
)
M
N
 c
el
ls
 p
53
kd
(1
9 
ce
lls
)
M
N
 c
el
ls
 w
t
(1
2 
ce
lls
)
3-somy
4-somy
state
0-somy
1-somy
2-somy
3-somy
4-somy
state
0-somy
1-somy
2-somy
chromosome #
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19202122 X
chromosome #
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19202122 X
chromosome #
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19202122 X
chromosome #
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19202122 X
chromosome #
chromosome #
Lo
g2
 ra
tio
2
-2
0
P
ar
en
ta
l p
53
kd
P
ar
en
ta
l w
t
Figure 1. Induced Aneuploidy Using MPS1i/CENP-Ei Combinatory Treatment
(A) Schematic overview of the experimental setup to harvest single cells after induced chromosome missegregation.
(B) Genome-wide chromosome copy number profile of RPE-1 WT cells as determined by CNV sequencing (CNV-seq).
(legend continued on next page)
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2016) indeed resulted in massive chromosome missegregations
(92%of cell divisions) (Figures S2A–S2C), often accompanied by
the formation of micronuclei (Figures S2D and S2E). However,
using this dose, we observed a large number of chromosome
bridges, previously shown to be susceptible to breakage and for-
mation of structural aneuploidies (Janssen et al., 2011). Because
we alsowanted to study the effects of whole-chromosome aneu-
ploidies, we set out to increase the amount of whole-chromo-
some missegregations. To this end, we combined a low dose
of the MPS1 inhibitor (NMS-P715) with an allosteric inhibitor of
the CENP-E kinesin (GSK923295) (Qian et al., 2010). The
concept of co-inhibition of CENP-E and the spindle assembly
checkpoint (SAC) has been explored before (Bennett et al.,
2015; Ohashi et al., 2015), but here we adjusted the system to
induce chromosome aneuploidies without delaying cells in
mitosis. CENP-E inhibition causes chromosomes to remain at
the spindle poles (1.7 ± 1.11 chromosomes per pole on average,
as determined by centromere staining). Combining a CENP-E
inhibitor with a low dose of MPS1 inhibitor resulted in a large
amount of polar chromosome missegregations as compared
with treatment with MPS1 inhibitor alone (55% versus 17%;
see Figures S2C–S2E). Importantly, mitotic duration using the
combination of drugs is comparable with that of untreated cells
(Figure S2F), and only a subset of missegregating chromosomes
end up in a micronucleus (Figure S2E). The majority of these
micronuclei contains only one chromatid, a subset contains no
centromere (indicating that they contain broken chromosome
fragments), and another subset contains two centromeres (likely
derived from a polar chromosome pair) (Figure S2G).
To reveal the aneuploidies we induce with our system, we
used single-cell sequencing to determine the copy number vari-
ation per cell (Bakker et al., 2016; van den Bos et al., 2016). First,
we performed single-cell plating of cells that were treated over-
night with the combination of CENP-E inhibitor and MPS1 inhib-
itor (Figure 1A). Because not all cells displayed a missegregation
event upon treatment (Figure S2C), we decided to select only
cells that harbored amicronucleus as amarker for amissegrega-
tion event. Untreated cells were used as a control. Micro-
amplifications or abnormalities around regions with repetitive
sequences such as centromeres were not counted as genuine
events, as they potentially are a consequence of incorrect ‘‘call-
ing’’ due to noise or low read counts. Both copy number variation
(CNV) analysis and single-cell sequencing analysis showed that
the parental, untreated RPE-1 wild-type cells harbor a gain of the
q-arm of chromosome 10 (Figures 1B and 1C). This gain is a
result of a known unbalanced translocation of chromosome
10q to the X chromosome (Janssen et al., 2011; ATCC). Further-
more, we find a subset of cells containing three copies of chro-
mosome 12. Although the origin of this event is unclear, it has
been previously described (Zhang et al., 2015) and is likely a
spontaneous, early event. Because these abnormalities are(C) Genome-wide chromosome copy number profile of RPE-1 WT cells as dete
previously (Bakker et al., 2016; van den Bos et al., 2016). Each row represents a
depict copy number state.
(D) Genome-wide copy number profile of micronucleated RPE-1 WT cells after ov
inhibitor (480 nM) as determined by single-cell sequencing.
(E–G) Same as (B), (C), and (D) but for RPE-1 p53kd cells.already present in the parental cells, we do not score these as
de novo aneuploidies. A gain of chromosome 20 could be
observed in 1 of 22 cells analyzed, indicating that RPE-1 cells
display a basal but low level of chromosome instability. As ex-
pected, the micronucleated cells harvested after drug treatment
displayed a large number of chromosome imbalances. As many
as 84% had acquired de novo aneuploidies, and 75% of all cells
displayed aneuploidies that involved whole chromosomes (i.e.,
numerical aneuploidies) (Figure 1D). Gains and losses of chro-
mosomes fragments were found in 42%of the cells and are likely
a result of chromosomes that were broken after anaphase (i.e.,
structural aneuploidies). Similar to the wild-type (WT) cells, the
p53kd cells also displayed an occasional gain of chromosome
12 and the gain of the 10q arm. In addition, a subset of cells dis-
played a more complex profile of chromosome 10, where an
additional loss of a part of the chromosome 10p arm could be
observed, an event that could also be detected in the CNV anal-
ysis (Figures 1E and 1F). Importantly, loss of p53 resulted in a
more unstable karyotype as multiple gains and losses could
already be observed before treatment (Figure 1F), an observa-
tion consistent with what was previously seen in organoids
(Drost et al., 2015). The p53kd micronucleated cells resulting
from the treatment with the drug combination displayed an addi-
tional, severe increase in the amount of chromosome imbal-
ances, comparable with the effects seen in RPE-1 WT cells
(95% had acquired de novo aneuploidies). Ninety percent of all
cells displayed aneuploidies that involved whole-chromosome
imbalances, and 68% of the cells displayed structural imbal-
ances (Figure 1G). It is important to note that most micro-
nuclei-containing cells must have additional aneuploidies in the
mother nucleus, because the majority of cells display multiple
gains and losses (Figures 1D and 1G), while the micronucleus
on average contained only one chromatid (Figure S2G). Taken
together, these data demonstrate that combining CENP-E and
MPS1 inhibitors is an efficient strategy to induce both whole-
chromosome and structural chromosome missegregations
without inducing a mitotic delay.
Aneuploidy Does Not Invariably Trigger
a p53-Dependent Cell-Cycle Arrest
To determine the effect of induced aneuploidy on cell fate, we
performed live cell imaging of cells in the presence of CENP-E
inhibitor and MPS1 inhibitor to induce a missegregation event.
After 10 hr, drugs were removed from the cells, and we imaged
the cells for an additional 82 hr to determine the capacity of
these cells to enter a second mitosis (see Figure 2A for experi-
mental setup). To be consistent with our single-cell sequencing
analysis, we traced only cells that contained amicronucleus after
the first division. We found that the majority of micronucleated
p53kd cells underwent a second mitosis (Figure 2B). Strikingly,
we found that a large proportion of micronucleated WT cellsrmined by single-cell sequencing using the AneuFinder pipeline as described
single cell, with chromosomes plotted as columns. Different colors are used to
ernight treatment with the combination of CENP-E inhibitor (50 nM) and MPS1
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Figure 2. Aneuploidy Does Not Invariably Trigger a p53-Dependent Cell-Cycle Arrest
(A) Experimental setup to trace micronucleated cells for their capability to enter a subsequent mitosis.
(B) Cumulative mitotic entry of RPE-1 WT and RPE-1 p53kd cells stably expressing H2B-Dendra2 that were treated with the combination of CENP-E inhibitor
(50 nM) andMPS1 inhibitor (480 nM). Time point 0 represents time of themissegregation event in the presence of drugs. Only cells that containedmicronuclei and
that could be traced for at least 52 hr were included. A total of 35 WT and 34 p53kd cells were analyzed. Images were taken every 10 min.
(C) Cells were treated as in (B). Only the sisters of micronucleated cells that did not contain micronuclei themselves and that could be traced for at least 52 hr were
included. A total of 26 WT and 26 p53kd cells were analyzed from three independent experiments.
(D) Representative images of RPE-1WT cells used to determine the percentage of p53 positivity by immunofluorescence staining. Thymidine-released cells were
treated with the indicated inhibitors overnight. Inhibitors were washed out in the morning, and cells were fixed and stained 24 hr post-washout. As a control, cells
were either left untreated or were treated for 3 hr with Etoposide (10 mM). The scale bar represents 10 mm.
(E) Quantification of p53-positive cells from cells in (D). Cells were identified on the basis of DAPI, and a pre-set threshold was used to determine p53 positivity.
One hundred cells were analyzed in the untreated and etoposide condition and 148 MN cells treated with MPS1 and CENP-E inhibitors.(40%) also divided again (Figure 2B), even though >80% of
these cells had become aneuploid (Figure 1D). This clearly indi-
cates that p53 does not invariably arrests all aneuploid cells in
response to a missegregation event. A similar effect could be
seen on the sisters of the micronucleated cells (Figure 2C), indi-2426 Cell Reports 19, 2423–2431, June 20, 2017cating that this effect is not specific to micronucleated cells but
applies to aneuploid cells in general. In line with that, we
observed upregulation of p53 in only a fraction (16%) of fixed
post-anaphase micronucleated cells (Figures 2D and 2E). This
fraction is lower than would be expected from our live cell
AB
C
D
(legend on next page)
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experiments, because approximately 40% of micronucleated
cells arrest in a p53-dependent manner (Figures 2B and 2C).
However, because quantification of p53 is performed at a fixed
time point, this may lead to a underestimation of the fraction of
cells that activates p53, as p53 is known to oscillate in response
to DNA damage (Batchelor et al., 2011). Taken together, our data
clearly shows that aneuploidy does not always result in p53
activation.
Propagation of Structural Aneuploidies Is Limited
to p53-Deficient Cells
We next determined which type of aneuploidies could be propa-
gated in p53-proficient versus p53-deficient cells. To this end,
we first evaluated the overall extent of aneuploidy obtained by
MPS1i/CENP-Ei treatment (referred to as the ‘‘starting popula-
tion’’) and compared this with the extent of aneuploidy in cells
that were still actively cycling 3 days post-MPS1i/CENP-Ei treat-
ment (on the basis of BrdU incorporation; referred to as ‘‘cycling
population’’) (see Figure 3A for experimental setup). Single-cell
sequencing of the starting population revealed that an equal
fraction of RPE-1 WT and p53kd cells became aneuploid upon
the combinatory treatment (66.7% and 68.4%, respectively)
(Figures 3B and 3C, top, and Figure 3D) but that the p53kd cells
contained slightly more numerical and structural chromosomal
alterations per cell, consistent with our previous results (Figures
1D and 1G). Importantly, the extent of aneuploidy decreased
significantly in the cycling WT RPE-1 population but not in the
p53kd RPE-1 cells (Figures 3B and 3C, bottom, and Figure 3D).
Remarkably, whole-chromosome aneuploidies appeared to be
quite well tolerated in both settings, whereas structural aneu-
ploidies could hardly be observed in WT cells that were still
proliferating 3 days post-treatment (Figure 3D). This indicates
that tolerance toward the structural aneuploidies we induce by
combined CENP-E/MPS1 inhibition is strongly influenced by
the p53 status of the cell.
Because we observed that aneuploid cells were still prolifer-
ating after 3 days, we reasoned that we should be able to
generate full aneuploid clones, both in WT and p53kd RPE-1
cells. Importantly, tracing of the subsequent divisions of single
cells over a multi-week time course (Figure S3A) showed that
only 23% of the untreated single RPE-1 WT cells had the ability
to grow out to a full clone, indicating that the proliferative capa-
city of RPE-1 WT cells is severely hampered when plated as
single cells (Figure S3B). Micronucleated RPE-1 WT cells
showed an even worse outcome, as the majority of cells did
not divide at all or stopped dividing after one or two cell divisions
(Figure S3B). However, two cells (1% of the starting population)
continued to divide over the whole duration of the experiment
and grew into full colonies (clones B18 and F12). To increaseFigure 3. Propagation of Structural Aneuploidies Is Limited to p53-Defi
(A) Schematic overview of the experimental setup to sequence single cells directly
actively cycling 96 hr post-treatment.
(B) Genome-wide chromosome copy number profile of RPE-1 WT cells as determ
with chromosomes plotted as columns. Different colors are used to depict copy
(C) Same as in (B) but for RPE-1 p53kd cells.
(D) Percentage of cells from (B) and (C) harboring only whole-chromosome ane
whole-chromosome aneuploidies) were determined per condition.
2428 Cell Reports 19, 2423–2431, June 20, 2017the clonal outgrowth of single-cell micronucleated WT RPE-1
cells, we removed the synchronization step and performed a
transient depletion of p53 by small interfering RNA (siRNA) trans-
fection 24 hr prior to the experiment. This approach notably
increased the success of single-cell outgrowth of untreated
WT cells as well as of the micronucleated WT cells, resulting in
three full colonies (clones B22, A11, and I18, 6% of the starting
population) (Figure S3C). In parallel, we performed similar exper-
iments in the RPE-1 p53kd cells, which tolerated single-cell
plating better (Figure S3D, left). Also, outgrowth of single micro-
nucleated p53kd cells was more effective with 17% growing into
full clones (Figure S3D, right).
To determine the exact ploidy of the clones that grew out from
the single micronucleated cells, we performed CNV analysis. In
the WT background, 3 clones had a similar ploidy as the WT
parentals, whereas 2 clones displayed a whole-chromosome
aneuploidy: a trisomy of chromosome 6 in clone A11 and amono-
somy of chromosome 10 in clone I18 (Figure 4A). Interestingly, all
cloneswere still p53 proficient as cell proliferationwas blocked by
Nutlin-3 (Figure S4; for technical reasons, clone A11 was lost and
could therefore not be tested for Nutlin-3 sensitivity). Interestingly,
in the clones derived from the p53kd cells, more severe aneu-
ploidies could be observed (Figure 4B), with only 2 clones dis-
playing the parental karyotype (clones K14 and E8). In contrast,
the other 12 clones displayed either only numerical (clones C23,
O8, D12, and I21), only structural (clone O9), or a combination
of numerical and structural changes (clones F9, H21, E18, F13,
I20, F20, and F6) (Figure 4B, right). These results imply that
whole-chromosome aneuploidies can be tolerated in p53-profi-
cient cells, whereas the propagation of structural aneuploidies
is restricted to p53-deficient backgrounds.
DISCUSSION
p53 Does Not Sense Aneuploidy Per Se
Although aneuploidy induced by SAC deficiency is lethal in
mouse embryonic fibroblasts (MEFs) (at least in part) because
of p53-induced apoptosis (Burds et al., 2005), stable aneuploid
MEFs do not show elevated p53 levels (Tang et al., 2011).
Also, SAC deficiency is tolerated in the murine interfollicular
epidermis, suggestive of limited p53 activation (Foijer et al.,
2013). Nonetheless, a p38/p53-dependent cell-cycle arrest has
been reported in response to chromosome missegregation
events in cell culture (Thompson and Compton, 2010), and
elevated levels of p53 have been observed at least in the CNS
of Down syndrome patients (Liao et al., 2012). Thus, whether
p53 can sense aneuploidy per se has remained controversial.
Here, we set up a system to induce both numerical and struc-
tural aneuploidies. Using this system, we found that p53 iscient Cells
after a whole-chromosomemissegregation event as well as cells that were still
ined by single-cell sequencing as in Figure 1. Each row represents a single cell,
number state.
uploidies or cells harboring structural aneuploidies (with or without additional
AB
Figure 4. Characterization of Aneuploid Clones
(A) Genome-wide chromosome copy number profile as determined by CNV-seq of five RPE-1 WT clones and their parental cell line. Chromosome gains are
depicted in red and losses in blue. Alteration of chromosomes 10 and 12 that are already present in the parental cells are not highlighted.
(B) Genome-wide chromosome copy number profile as determined by CNV-seq of 14 RPE-1 p53kd clones and their parental cell line. Chromosome gains are
depicted in red and losses in blue. Gains or losses that are less than what would be expected from amonosomic event (a log2 ratio >1) or from a trisomic event
(a log2 ratio < 0.5) might reflect non-full clonal losses or gains and are depicted in orange and light blue, respectively.upregulated in only a fraction of the non-transformed, p53-profi-
cient human cells after a missegregation event and that a large
fraction of cells will continue to divide after a missegregationevent. Moreover, we found that even multiple days after the mis-
segregation event, p53-proficient cells can be observed that
are actively proliferating in the presence of whole-chromosomeCell Reports 19, 2423–2431, June 20, 2017 2429
imbalances. Finally, we were able to generate stable p53-profi-
cient cell clones harboring a whole-chromosome aneuploidy.
These results suggest that p53 is not always activated in
response to aneuploidy, and therefore whole-chromosome im-
balances can be stably propagated in p53-proficient cells.
Mild Whole-Chromosome Aneuploidies Can Be
Tolerated and Propagated in a p53-Proficient
Background
Our data show that at least a subset of whole-chromosome
aneuploidies can be tolerated in p53-proficient cells. However,
the fact that the total amount of whole-chromosome abnormal-
ities per cell drops significantly in the proliferating population of
WT cells compared with the p53-deficient cells after 3 days sug-
gests that whole-chromosome aneuploidy can sometimes acti-
vate p53 to the extent that does prevent further proliferation.
Likely, the degree of aneuploidy is an important determinant
here. As has been shown before, the higher the level of aneu-
ploidy, the more cellular imbalances occur, leading to increased
levels of cellular stress (Torres et al., 2007). Possibly, when the
level of stress exceeds a certain threshold, p53 becomes acti-
vated to levels that prevent proliferation. Alternatively, particular
whole-chromosome imbalances may be not tolerated because
they could lead to perturbations in very specific, essential cellular
processes.
Propagation of Structural Aneuploidies Is Limited to
p53-Deficient Cells
By single-cell sequencing of actively proliferating aneuploid cells
(Figure 3), we revealed that p53 prevents cells that harbor struc-
tural aneuploidies to proliferate. We have previously shown that
structural chromosomal aberrations can result from chromo-
somal missegregations that induce chromosome breakage
(Janssen et al., 2011). As broken chromosomes activate the
DNA damage checkpoint through the activation of ATM, it is
likely that p53 gets activated in response to these types of
segregation errors. Indeed, although structural aneuploidies
are induced to the same extent in both p53-proficient and p53-
deficient cells, propagation of these structural aneuploidies is
limited to the p53-deficient cells (Figures 3 and 4). Interestingly,
although numbers are small, single-cell sequencing of aneuploid
cells indicates that chromosome breakage occurs more often in
large chromosomes, suggesting that larger chromosomes are
more likely to break when the SAC is compromised compared
with the smaller chromosomes. This may reflect a selective
effect on larger chromosomes or may simply be a consequence
of increased size.
Our results suggest that DNA breaks induced by chromosome
missegregation events result in a permanent cell-cycle arrest
in p53-proficient cells. However, it is important to point out
that the WT RPE-1 cells stably propagate a structural aneu-
ploidy, namely, the translocation of 10q to chromosome X,
indicating that structural aneuploidies per se do not prohibit
proliferation of p53-proficient cells. This suggests that the
manner in which the structural aneuploidy is generated will
determine if it can be propagated in a p53-proficient setting
and that structural aneuploidies that arose through a different
mechanism, such as a recombination event, can be propagated2430 Cell Reports 19, 2423–2431, June 20, 2017in p53-proficient cells. Taken together, we find that a whole-
chromosome imbalance per se is not sufficient to induce a
p53-dependent cell-cycle arrest and that at least a subset of
whole-chromosome aneuploidies can be tolerated and propa-
gated. In contrast, structural aneuploidies that are produced
by chromosome missegregation are solely tolerated and propa-
gated in p53-deficient cells.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
hTERT-immortalized RPE-1 were from ATCC. RPE-1 p53kd cells were
generated by transduction with pRetroSuper-p53 (with the shRNA sequence
50-CTACATGTGTAACAGTTCC-30) and selected with Nutlin-3 for functional
loss of p53. Cell culture and synchronization procedures were described pre-
viously (Janssen et al., 2011). Inhibitors were all dissolved in DMSO and were
used at the following concentrations: proTAME, 20 mM; GSK923295, 50 nM;
NMS-P715, 480 nM; Cpd-5, 200 nM; and Nutlin3a, 10 mM.
Time-Lapse Imaging
For live-cell imaging, cells were grown in Lab-Tek II chambered coverglass
(Thermo Fisher Scientific). Imaging was performed as previously described
(Koch et al., 2016).
siRNA Transfection
ON-TARGETplus SMARTpool siRNA targeting p53 (Thermo Fisher Scientific)
was transfected using RNAiMAX (Life Technologies) according to the manu-
facturer’s protocol in a final concentration of 20 nM, 24 hr before the start of
the experiment.
Immunofluorescence
Cells were grown on 10-mm glass coverslips and fixed in 3.7% formaldehyde/
0.5%Triton X-100 in PBS for 15min at room temperature. Primary antibody for
p53 (sc-126; Santa Cruz) was incubated at 4C overnight, and secondary
antibody (Alexa Fluor 488; Molecular Probes) was incubated for 2 hr at room
temperature, both dissolved in PBS 0.1% Tween. DAPI was added to all
samples before mounting using Vectashield mounting fluid (Vector Labora-
tories). Images were acquired on a DeltaVision Elite microscope (Applied
Precision), taking 200-nm z stacks with a PlanApo N 603/NA 1.42 objec-
tive (Olympus) and a Coolsnap HQ2 camera (Photometrics). Images were
analyzed after deconvolution using SoftWoRx (Applied Precision). Figures
are maximum-intensity projection of entire cells. Brightness and contrast
were adjusted with Photoshop 6.0 (Adobe).
Copy Number Analysis
For a detailed description of the methods used for CNV and single-cell
sequencing, see Supplemental Experimental Procedures.
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